Oxurion NV (OXUR) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.097x

Based on the latest financial reports, Oxurion NV (OXUR) has a cash flow conversion efficiency ratio of 0.097x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.16 Million ≈ $-1.36 Million USD) by net assets (€-11.99 Million ≈ $-14.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Oxurion NV (OXUR) net asset quality to measure how much of total assets are equity-financed.

Oxurion NV - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Oxurion NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check OXUR cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Oxurion NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oxurion NV ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Eden Research plc LSE:EDEN	-0.048x
Exploitasi Energi Indonesia JK:CNKO	-0.069x
First Merchants Corporation Depository Shares NASDAQ:FRMEP	0.022x
First Eagle Alternative Capital BDC Inc NYSE:FCRX	0.022x
Global PVQ SE HM:QCE	3.126x
Cobalt Power Group Inc V:PGP	0.085x
Atlas Corp NASDAQ:ATCOL	0.083x
Benson Hill, Inc. Common Stock NYSE:BHIL	-0.533x

Annual Cash Flow Conversion Efficiency for Oxurion NV (2006–2024)

The table below shows the annual cash flow conversion efficiency of Oxurion NV from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Oxurion NV stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-11.06 Million ≈ $-12.93 Million	€-2.07 Million ≈ $-2.42 Million	0.187x	-74.75%
2023-12-31	€-13.19 Million ≈ $-15.42 Million	€-9.77 Million ≈ $-11.42 Million	0.741x	-83.04%
2022-12-31	€-4.58 Million ≈ $-5.36 Million	€-20.02 Million ≈ $-23.40 Million	4.367x	-82.18%
2021-12-31	€-1.11 Million ≈ $-1.30 Million	€-27.16 Million ≈ $-31.75 Million	24.508x	+2365.49%
2020-12-31	€25.05 Million ≈ $29.28 Million	€-27.10 Million ≈ $-31.68 Million	-1.082x	-85.42%
2019-12-31	€53.31 Million ≈ $62.32 Million	€-31.10 Million ≈ $-36.36 Million	-0.583x	-97.46%
2018-12-31	€105.31 Million ≈ $123.12 Million	€-31.12 Million ≈ $-36.38 Million	-0.295x	-249.85%
2017-12-31	€133.36 Million ≈ $155.91 Million	€26.30 Million ≈ $30.74 Million	0.197x	+206.66%
2016-12-31	€109.86 Million ≈ $128.44 Million	€-20.31 Million ≈ $-23.74 Million	-0.185x	-13.08%
2015-12-31	€170.01 Million ≈ $198.77 Million	€-27.79 Million ≈ $-32.49 Million	-0.163x	+27.00%
2014-12-31	€208.01 Million ≈ $243.19 Million	€-46.58 Million ≈ $-54.46 Million	-0.224x	-325.38%
2013-12-31	€258.77 Million ≈ $302.53 Million	€25.71 Million ≈ $30.06 Million	0.099x	-18.50%
2012-12-31	€227.97 Million ≈ $266.52 Million	€27.79 Million ≈ $32.49 Million	0.122x	+173.54%
2011-12-31	€118.03 Million ≈ $137.99 Million	€-19.56 Million ≈ $-22.87 Million	-0.166x	-36.00%
2010-12-31	€138.19 Million ≈ $161.56 Million	€-16.84 Million ≈ $-19.69 Million	-0.122x	+5.59%
2009-12-31	€93.72 Million ≈ $109.57 Million	€-12.10 Million ≈ $-14.14 Million	-0.129x	-167.36%
2008-12-31	€62.39 Million ≈ $72.94 Million	€11.96 Million ≈ $13.98 Million	0.192x	+162.73%
2007-12-31	€48.44 Million ≈ $56.63 Million	€-14.80 Million ≈ $-17.30 Million	-0.306x	-28.03%
2006-12-31	€35.28 Million ≈ $41.24 Million	€-8.42 Million ≈ $-9.84 Million	-0.239x	--

About Oxurion NV

BR:OXUR Belgium Biotechnology

Market Cap

$248.85K

€212.86K EUR

Market Cap Rank

#31141 Global

#112 in Belgium

Share Price

€0.00

Change (1 day)

-14.29%

52-Week Range

€0.00 - €0.03

All Time High

€102000.00